Sharon Barbari
Director/Board Member at AGILE THERAPEUTICS, INC.
Net worth: 3 527 $ as of 2024-03-30
Profile
Sharon Barbari is an Independent Director at Agile Therapeutics, Inc. and VYNE Therapeutics, Inc. She previously served as an Independent Director at Sonoma Pharmaceuticals, Inc. from 2014 to 2021.
She also held positions as a Director at VYNE Pharmaceuticals Ltd., Menlo Therapeutics, Inc., and Phytogen Life Sciences.
Additionally, she was a Director at The Association of Bioscience Financial Officers from 2007 to 2021.
Ms. Barbari has a background in finance and served as the Chief Financial Officer at Gilead Sciences, Inc. from 1998 to 2002.
She also held the position of CFO, Senior VP-Finance & Administration at InterMune, Inc. from 2002 to 2004, and Chief Financial Officer, Secretary & Executive VP at Cytokinetics, Inc. from 2004 to 2017.
Prior to her roles in the biotech industry, she was Vice President-Strategic Planning at Foote, Cone & Belding Healthcare.
Ms. Barbari obtained her undergraduate degree from San Jose State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VYNE THERAPEUTICS INC
0.01% | 2024-02-13 | 1,041 ( 0.01% ) | 3 196 $ | 2024-03-30 |
AGILE THERAPEUTICS, INC.
0.01% | 2023-06-07 | 974 ( 0.01% ) | 331 $ | 2024-03-30 |
Sharon Barbari active positions
| Companies | Position | Start |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Director/Board Member | 2020-06-08 |
| VYNE THERAPEUTICS INC. | Director/Board Member | 2020-02-29 |
Former positions of Sharon Barbari
| Companies | Position | End |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director/Board Member | 2021-09-14 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Director/Board Member | 2020-12-31 |
| CYTOKINETICS, INCORPORATED | Director of Finance/CFO | 2017-06-25 |
| INTERMUNE INC | Director of Finance/CFO | 2004-07-31 |
| GILEAD SCIENCES, INC. | Director of Finance/CFO | 2002-05-31 |
Training of Sharon Barbari
| San Jose State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| AGILE THERAPEUTICS, INC. | Health Technology |
| VYNE THERAPEUTICS INC. | Health Technology |
| Private companies | 6 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
| Foote, Cone & Belding Healthcare | |
Phytogen Life Sciences
 Phytogen Life Sciences Agricultural Commodities/MillingProcess Industries Phytogen Life Sciences provides cotton production services. The private company is based in Indianapolis, IN. | Process Industries |
- Stock Market
- Insiders
- Sharon Barbari
